This study not only demonstrated the exciting therapeutic effect of ASO 10–27 but also suggested that the rescue of SMN expression in peripheral tissues was necessary for the treatment of SMA, opening a new avenue in academic research. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.